Tech Company Financing Transactions
Lucigen Funding Round
Private investors participated in a $2 million funding round for Lucigen. The financing was announced on 1/16/2015.
Transaction Overview
Company Name
Announced On
1/16/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2905 Parmenter St.
Middleton, WI 53562
USA
Middleton, WI 53562
USA
Phone
Website
Email Address
Overview
At Lucigen, we deliver solutions to current problems in DNA cloning, sequencing, amplification, and protein expression by providing exceptionally reliable products and services to life science researchers. With a focus on quality and customer service we strive to make your time in the laboratory productive and successful.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ralph Kauten
Chief Financial Officer
Holly Backhaus
Chief Scientific Officer
David Mead
President
Jeffrey Williams
VP - Marketing
Angela Ryan
VP - Operations
Jay Schiestle
VP - Regulatory Affairs
Ray Bandziulis
Browse more venture capital transactions:
Prev: 1/15/2015: ClassPass venture capital transaction
Next: 1/16/2015: Global Debt Registry venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs